Our researchers at the Center for the Evaluation of Value and Risk in Health (CEVR), including CEVR Director Peter J. Neumann, ScD, frequently contribute their knowledge to a wide range of prestigious, peer-reviewed journals.

Chambers JC, Weiner DE, Bliss SK, Neumann PJ. What can we learn from the US expanded end-stage renal disease bundle? Health Policy. 2013; (110):164-171. PMID: 23419419

Lerner D, Rodday AM, Cohen JT, Rogers WH. A Systematic Review of the Evidence Concerning the Economic Impact of Employee-Focused Health Promotion and Wellness Programs. J Occup Environ Med. 2013 Jan 2. [Epub ahead of print] PMID: 23287723

Lin PJ, Neumann PJ. The economics of mild cognitive impairment. Alzheimers and Dementia. 2013; (9):58–62. PMID: 23141385

Lin PJ, Fillit HM, Cohen JT, Neumann PJ. Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders. Alzheimer’s & Dementia 9 (2013) 30–38. PMID: 23305822

Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD. The Validity of Dependence as a Health Outcome Measure in Alzheimer's Disease. Am J Alzheimers Dis Other Demen. 2013 Mar 19. [Epub ahead of print] PMID: 23512996

Barshes NR, Chambers JD, Cohen JT, Belkin M. Cost Effectiveness in the contemporary management of critical limb ischemia with tissue loss. Journal of Vascular Surgery. 2012 Oct;56(4):1015-1024.PMID: 22854267

Barshes NR, Chambers JD, Cantor SB, Cohen J, Belkin M. A primer on cost-effectiveness analyses for vascular surgeons. Journal of Vascular Surgery. 2012 Jun;55(6):1794-800.PMID: 22608043

Cangelosi MJ, Bliss SK, Chang H, Dubois RW, Lerner D, Neumann PJ, Westrich K, Cohen JT. Imputing productivity gains from clinical trials. Journal of Occupational and Environmental Medicine.2012 Jul;54(7):826-33.PMID: 22796927

†Chambers JD, Morris S, Neumann PJ, Buxton MJ. Factors Predicting Medicare National Coverage. Medical Care. 2012 Mar;50(3):249-56.PMID: 22193418

Cohen JT, Marino RJ, Sacco P, Terrin N. Association between the Functional Independence Measure following spinal cord injury and long term outcomes. Spinal Cord. 2012 Oct;50(10):728-33.PMID: 22641254

Cohen JT, Miller G, Roehrig C. Cost-Effectiveness of Cardiovascular Disease Spending. Journal of the American College of Cardiology. 2012;60(20):2123-2124.PMID: 22193418

Doshi JA, Hodgkins P, Kahle J, Sikirika V, Cangelosi MJ, Setyawan J, Erder MH, Neumann PJ. Economic Impact of Childhood and Adult Attention-Deficit. Hyperactivity Disorder in the United States. Journal of the American Academy of Child & Adolescent Psychiatry. 2012 October; 51(10): 990-1002.PMID: 23021476

Drummond M, Neumann PJ, Jonsson B, Luce B, Schwartz JS, Siebert U, Sullivan SD. Can we reliably benchmark health technology assessment organizations? International Journal of Technology Assessment in Health Care. 28:2(2012):159-165.PMID: 22559758

Geisler BP, Egan BM, Cohen JT, Garner AM, Akehurst RL, Esler MD, Pietzsch JB. Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension. Journal of the American College of Cardiology 2012; 60(14):1271-7.PMID: 22981547

Gray GM, Cohen JT. Rethink Chemical Risk Assessments. Nature. 2012 Sep 6;489(7414):27-8.PMID: 22955594

Hammerman A, Feder-Bubis P, Greenberg D. Financial risk-sharing in updating the national list of health services in Israel: stakeholders' perceived interests. Value in Health. 2012 Jul-Aug;15(5):737-42.PMID: 22867784

Leslie LK, Cohen JT, Newburger JW, Alexander ME, Wong JB, Sherwin ED, Rodday AM, Parsons SK, Triedman JK. Costs and benefits of targeted screening for causes of sudden cardiac death in children and adolescents. Circulation. 2012 May 29;125(21):2621-9.PMID: 22556340

Luce BR, Drummond MF, Dubois RW, et al. Principles for planning and conducting comparative effectiveness research. Journal of Comparative Effectiveness Research. 2012; 1(5): 431-440.

Lin PJ, Neumann PJ. The economics of mild cognitive impairment. Alzheimers and Dementia. 2012;1-5.PMID: 23141385

Neumann PJ, Bliss SK. FDA actions against health economic promotions, 2002-2011. Value in Health.2012 Sep;15(6):948-53.PMID: 22999146

Neumann PJ, Bliss SK, Chambers JD. Therapies for advanced cancers pose a special challenge for health technology assessment organizations in many countries. Health Affairs. 2012 Apr;31(4):700-8.PMID: 22492886

Neumann PJ, Chambers JD. Medicare's enduring struggle to define 'reasonable and necessary' care. New England Journal of Medicine. 2012 October 31.367(19):1775-1777.

Neumann PJ, What we talk about when we talk about health care costs. New England Journal of Medicine. 2012 Feb;366(7):585-86.PMID: 22335735

Neumann, PJ, Cohen, JT, Hammitt, JK, Concannon, TW, Auerbach, HR, Fang, CH, Kent, DM. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Economics. 2012 Mar;21(3):238-51.PMID: 22271512

O’Grady MJ, John P, Winn A. Substantial Medicare savings may result if insurers cover ‘artificial pancreas’ sooner for diabetes patients. Health Affairs. 2012 Aug;31(8):1822-9.PMID: 22869661

Otero HJ, Chambers JD, Bresnahan BW, Kamae MS, Yucel KE, Neumann PJ. Medicare's National Coverage Determinations in Diagnostic Radiology: Examining Evidence and Setting Limits. Academic Radiology. 2012 Sep;19(9):1060-5.PMID: 22748382

Rodday AM, Triedman JK, Alexander ME, Cohen JT, Ip S, Newburger JW, Parsons SK, Trikalinos TA, Wong JB, Leslie LK. Electrocardiogram screening for disorders that cause sudden cardiac death in asymptomatic Children: A meta-analysis. Pediatrics. 2012 Apr;129(4):e999-1010.PMID: 22392183

*Thorat T, Cangelosi M, Neumann PJ. Skills of the trade: The Tufts cost-effectiveness analysis registry. Journal of Benefit-Cost Analysis. 2012 Feb;3(1):1-7.

Wilson AW, Neumann PJ, The cost-effectiveness of biopharmaceuticals: A look at the evidence. MAbs. 2012 Mar 1;4(2).PMID: 22377753

* Publication used data from CEA Registry
† Publication used data from NCD database

Buxton, MJ, Chambers, JD. What values do the public want their health care systems to use in evaluating technologies? European Journal of Health Economics. Published online May 15, 2011. PMID: 21573933

Cangelosi, MJ, Auerbach, HR, Cohen, JT. A clinical and economic evaluation of enteral nutrition. Current Medical Research Opinion. 2011 Feb;27(2):413-22. Epub 2010 Dec 30. PMID: 21192760

†Chambers JD, Morris S, Neumann PJ, Buxton M. Factors predicting Medicare national coverage: An empirical analysis. Medical Care. 2011 Dec 28. PMID: 22193418

Chambers J, Neumann PJ. Listening to Provenge — what a costly cancer treatment says about Medicare policy on new technology. New England Journal of Medicine. 2011 May 5;364(18):1687-9. PMID: 21470004

Gazelle GS, Kessler L, Lee DW, McGinn T, Menzin J, Neumann PJ, van Amerongen D, White LA. The Working Group on Comparative Effectiveness Research for Imaging. A framework for assessing the value of diagnostic imaging in the era of comparative effectiveness research. Radiology 2011 Dec;261(3):692-698. PMID: 22095993

*Greenberg, D., Neumann, PJ. Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions? Expert Reviews 2011. Published online 2011. PMID: 21351863

*Kamae MS, Kamae I, Cohen JT, Neumann PJ. Regression analysis on the variation in efficiency frontiers for prevention stage of HIV/AIDS. Journal of Medical Economics 2011. Published online 2011. PMID: 21332273

Maciejewski ML, Wang VW, Grabowski DC, Lin PJ. Early evidence on the quality of care provided by special needs plans. Medical Care 2011;49(10):891-896. PMID: 21572358

Neumann PJ, Chambers J, Simon F, Meckley L. Risk-sharing arrangements that link payment for drugs to health outcomes are proving hard to implement. Health Affairs. 2011 Dec; 30(4): 2329-2337. PMID:22147861

Neumann, PJ, Cohen, JT, Hammitt, JK, Concannon, TW, Auerbach, HR, Fang, CH, Kent, DM. Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Economics 2011. Published online Dec. 28, 2010. PMID: 21190163

Neumann PJ. What’s next for QALYs. Journal of the American Medical Association 2011 May; 305(17):1806-1807. PMID: 21540426

Neumann PJ, Lin PJ, Hughes TE. FDAMA Section 114: Current Uses and Opportunities for Comparative Effectiveness Research. Pharmacoeconomics 2011 July; 29(8):687-692. PMID: 21540426

Yang Z, Zhang K, Lin PJ, Clevenger CK, Atherly A. A longitudinal analysis of the lifetime cost of dementia. Health Services Research. 2011 Dec 15. PMID: 22171532.

 * Publication used data from CEA Registry
 † Publication used data from NCD database

Brixner, DI, Holtorf, AP, Neumann, PJ, Malone, DC, Watkins, JB Standardizing quality assessment of observational studies for decision making in health care. J Manag Care Pharm. 2009;15:(3)275-283. PubMed: 19326959

Berry SR, Bell CM, Ubel PA et al. Continental Divide? The Attitudes of US and Canadian Oncologists on the Costs, Cost-Effectiveness, and Health Policies Associated with New Cancer Drugs. J Clin Oncol 2010 PubMed: 20697077

Carlson JJ, Sullivan SD, Garrison LP, Neumann PJ, Veenstra DL. Linking payment to health outcomes: A taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy 2010; 96:179-190.

†Chambers JD, Neumann PJ, Buxton MJ. Does Medicare Have an Implicit Cost-Effectiveness Threshold? Medical Decision Making 2010. PubMed: 20551473

Chambers JD, Neumann PJ. US healthcare reform: implications for health economics and outcomes research. Expert Review Pharmacoeconomic Outcomes Research 2010; 10(3):215-216. PubMed: 20545583

Cohen JT, Neumann PJ. Using decision analysis to better evaluate pediatric clinical guidelines. Health Affairs. 2008 Sep-Oct;27(5):1467-75. PubMed: 18780939

Cohen JT, Neumann PJ, Weinstein MC. Does preventive care save money? Health economics and the presidential candidates. New England Journal of Medicine. 2008 Feb(7);358:661-663. PubMed: 18272889

Cohen JT. Walking speed and economic outcomes for walking-impaired patients with multiple sclerosis. Expert Review Pharmacoeconomic Outcomes Research 2010; 10(5):595-603. PubMed

Fillit H, Cummings J, Neumann PJ, McLaughin T. Salvatore P, Leibman C. Novel approaches to incorporating pharmacoeconomic studies into phase III clinical trials for Alzheimer’s disease. The Journal of Nutrition Health & Aging 2010; 14(8):640-647.c

Freeman RB, Cohen JT. Transplantation risks and the real world: what does 'high risk' really mean? Am J Transplant 2009; 9(1):23-30. PubMed: 19067660

Gabbay E, Calvo-Broce J, Meyer KB, Trikalinos TA, Cohen J, Kent DM. The empirical basics for determinations of medical futility. General Internal Medicine 2010; 25(10):1083-10839.

Garrison LP, Jr., Neumann PJ, Radensky P, Walcoff SD. A flexible approach to evidentiary standards for comparative effectiveness research. Health Affairs (Millwood) 2010; 29(10):1812-1817.

*Greenberg D, Earle CC, Fang CH, Eldar-Lissai A, Neumann PJ. When is cancer care cost-effective? A systematic overview of cost-utility studies in oncology. Journal of the National Cancer Institute 2010;102(2):82-88. PubMed: 20056956

*Greenberg D, Rosen AB, Wacht O, Palmer JA, Neumann PJ. A bibliometric review of cost-effectiveness analysis in the economic and medical literature, 1976-2007. Medical Decision Making. Published online March 2010. PubMed: 20228286

Jacobson PD, Neumann PJ. A framework to measure the value of public health services. Health Services Research. In press.

Kozminski MA, Neumann PJ, Nadler ES, Jankovic A, Ubel PA. How long and how well: oncologists’ attitudes toward the relative value of life-prolonging v. quality of life-enhancing treatments. Medical Decision Making. 2010. Published online, November 24, 2010.

Lin PJ, Kaufer DI, Maciejewski ML, Ganguly R, Paul JE, Biddle AK. An examination of Alzheimer’s case definitions using Medicare claims and survey data. Alzheimers and Dementia. PubMed: 20434960

Lin PJ, Maciejewski ML, Paul JE, Biddle AK. Risk adjustment for Medicare beneficiaries with Alzheimer’s disease and related dementias. American Journal of Managed Care 2010;16(3):191-198. PubMed: 20225914

Lin PJ, Shaya FT, Scharf SM. Economic implications of comorbid conditions among Medicaid beneficiaries with COPD. Respir Med. PubMed: 19954941

Luce BR, Drummond M, Jonsson B et al. EBM, HTA, and CER: clearing the confusion. Milbank Q 2010; 88(2):256-276 PubMed: 20579285

McLaughin T, Feldman H, Fillit H, Sano M, Schmitt F, Aisen P, Leibman C, Mucha L, Ryan MJ, Sullivan SD, Spackman DE, Neumann PJ, Cohen J, Stern Yaakov. Dependence as a unifying contruct in defining Alzheimer’s disease severity. Alzheimer’s and Dimentia 2010; 6(1):482-493.

Meckley LM, Neumann PJ. Personalized medicine: Factors influencing reimbursement. Health Policy 2010;94:91-100. PubMed: 19815307

*Neumann PJ, Auerbach HR, Cohen JT, Greenberg D. “Low-value” services in value-based insurance design. American Journal of Managed Care 2010;16(4):280-286. PubMed: 20394464

Neumann PJ, Drummond MF, Jönsson B, Luce B, Schwartz JS, Siebert U, Sullivan SD. Are key principles for improved health technology assessment supported and used by HTA organizations? International Journal of Technology Assessment in Health Care 2010 Jan;21(1):71-78. PubMed: 20059783

†Neumann PJ, Tunis SR. Medicare and medical technology – the growing demand for relevant outcomes. New England Journal of Medicine 2010;362(5):377-379. PubMed: 20089955

*Neumann PJ, Palmer JA, Fang CH, Nadler E, Ubel PA. Struggling with expensive new cancer therapies: A national survey of oncologists. Health Affairs 2010 Jan;29(1):196-202. PubMed: 20048377

Neumann PJ. American exceptionalism and American health care: Implications for the U.S. debate on cost-effectiveness analysis. Office of Health Economics Briefing. 2009;47.

Neumann PJ. Are mAbs different? A commentary on Cohen and Wilson. MaBs. 2009;1(1):29-30.

Neumann PJ. Costing and perspective in published cost-effectiveness analyses. Medical Care. 2009; 47(7s1):s28-s32. Pubmed: 19536023

Neumann PJ. Lessons for health technology assessment: It is not only about the evidence. Value in Health 2009; 12(s2):s45-s48. PubMed: 19523184

Neumann PJ. Whatever happened to FDAMA Section 114? A look back after 10 years. Value Health 2009; 12(2):189-190. PubMed: 18657100

Neumann PJ, Fang CH, Cohen JT. 30 years of pharmaceutical cost-utility analyses: growth, diversity, and methodological improvement. Pharmacoeconomics. In press.

Neumann PJ, Jacobson PD, Palmer JA. Measuring the value of public health systems: The disconnect between health economists and public health practitioners. American Journal of Public Health. 2008 Dec;98(12):2173-2180. PubMed:

Neumann PJ, Kamae MS, Palmer JA. Medicare’s national coverage decisions for technologies, 1999-2007. Health Affairs. 2008 Nov:27(6):1620-1631. PubMed:

Neumann PJ, Weinstein M.C. Legislating against use of cost-effectiveness information. New England Journal of Medecine 2010; 363(16):1495-1497. PubMed

*Otero HJ, Rybicki FJ, Greenberg D, Mitsouras D, Mendoza JA, Neumann PJ. Cost-Effective Diagnostic Cardiovascular Imaging: When Does It Provide Good Value for the Money? International Journal of Cardiovascular Imaging 2010. PubMed:

Otero HJ, Rybicki FJ, Greenberg D, Neumann PJ. 20 years of cost-effectiveness analysis in medical imaging: Are we improving?. Radiology. 2008 Dec;249(3):917-925. PubMed:

Palmer JA, Timm AR, Neumann PJ. Drug Company advertising in medical journals about the health-economic advantages of their products for 2000-2006 versus 1990-1999. Journal of Managed Care Pharmacy. 2008;14(8):749-55. PubMed:

Rothberg MB, Cohen JT, Lindenauer P, Maselli J, Auerbach AD. Little Evidence Of Correlation Between Growth In Health Care Spending And Reduced Mortality. Health Affairs (Millwood) 2010; 29(8):1523-1531.

Shaya FT, Yan X, Lin PJ, Simoni-Wastia L, Bron M, Baran R, Donner T. US Trends in Glycemic Control, Treatment, and Comorbidity Burden in Patients With Diabetes. Journal of Clinical Hypertension 2010;12(10):826–832.

 * Publication used data from CEA Registry
 † Publication used data from NCD database